Home › Companies › Ligand Pharmaceuticals Incorporated › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Ligand Pharmaceuticals Incorporated’s Form 8-K, filed June 9, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 5, 2026: 11 items on Ligand Pharmaceuticals Incorporated’s Form 8-K, filed June 9, 2026: 8 elected · 3 approved.
Notable dissent: 1 director (18.0% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore Ligand Pharmaceuticals Incorporated in the interactive database Compare manager voting policies
These tallies are Ligand Pharmaceuticals Incorporated’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 9, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Jason M. Aryeh | 14,373,659 | -- | -- | 3,160,100 | 1,257,231 | 82% | Elected | — |
| Elect Director: Todd C. Davis | 17,224,372 | -- | -- | 309,387 | 1,257,231 | 98% | Elected | — |
| Elect Director: Nancy R. Gray, Ph.D. | 16,915,084 | -- | -- | 618,675 | 1,257,231 | 96% | Elected | — |
| Elect Director: Jason Haas | 17,204,420 | -- | -- | 329,339 | 1,257,231 | 98% | Elected | — |
| Elect Director: John W. Kozarich, Ph.D. | 16,260,105 | -- | -- | 1,273,654 | 1,257,231 | 93% | Elected | — |
| Elect Director: John L. LaMattina, Ph.D. | 16,714,494 | -- | -- | 819,265 | 1,257,231 | 95% | Elected | — |
| Elect Director: Stephen L. Sabba, M.D. | 16,552,676 | -- | -- | 981,083 | 1,257,231 | 94% | Elected | — |
| Elect Director: Martine Zimmermann, Pharm.D. | 17,319,859 | -- | -- | 213,900 | 1,257,231 | 99% | Elected | — |
| 2. The ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 | 18,526,515 | 257,924 | 6,551 | -- | -- | 99% | Approved | — |
| 3. The approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers | 16,497,712 | 1,021,948 | 14,099 | -- | 1,257,231 | 94% | Approved | — |
| 4. The approval of an amendment and restatement of the Company's 2002 Stock Incentive Plan | 16,643,281 | 870,556 | 19,922 | -- | 1,257,231 | 95% | Approved | — |
Source: Ligand Pharmaceuticals Incorporated, Form 8-K, filed with the SEC on June 9, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
398 asset managers disclosed a vote on at least one Ligand Pharmaceuticals Incorporated item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Ligand Pharmaceuticals Incorporated’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 7 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
Prior year: 80.8% for (June 6, 2025 meeting) ▲ 1.2 pts
Description as filed by funds: Election of Directors: Jason M. Aryeh
Ligand Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Jason M. Aryeh”): 14,373,659 for, 3,160,100 withheld, per its Form 8-K filed June 9, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “In accordance with the results below, each nominee was elected to serve as a director of the Company.”
Support: 82% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 110 asset managers below reported 10,006,593 for, 970,252 withheld, 223,145 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,275,739 | 0 | 24 | 3,062 | For |
| BlackRock | 1,864,732 | 0 | 0 | 0 | For |
| Fidelity | 1,073,532 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| Invesco | 681,557 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 0 | 391,300 | Withhold |
| MFS | 357,693 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| DWS | 279,177 | 0 | 0 | 0 | For |
| Victory Capital | 234,777 | 0 | 0 | 0 | For |
| State Street | 2,618 | 0 | 0 | 206,651 | Withhold |
| Loomis Sayles | 0 | 0 | 192,458 | 0 | Abstain |
| Charles Schwab | 162,350 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 152,444 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 137,169 | 0 | 0 | 0 | For |
| Dimensional | 98,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 76,226 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 0 | 68,995 | Withhold |
| First Trust | 68,524 | 0 | 0 | 0 | For |
| Lincoln Financial | 12,482 | 0 | 0 | 51,975 | Mixed |
| OLD WESTBURY FUNDS INC | 62,425 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 60,342 | 0 | 0 | 0 | For |
| AMG FUNDS | 58,521 | 0 | 0 | 0 | For |
| Jackson National | 23,654 | 0 | 30,383 | 0 | Mixed |
Showing the 25 largest of 110 asset managers. All 110 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 98.8% for (June 6, 2025 meeting) ▼ 0.7 pts
Description as filed by funds: Election of Directors: Jason Haas
Ligand Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Jason Haas”): 17,204,420 for, 329,339 withheld, per its Form 8-K filed June 9, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “In accordance with the results below, each nominee was elected to serve as a director of the Company.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 110 asset managers below reported 11,198,089 for, 1,900 withheld, 1 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,278,824 | 0 | 1 | 0 | For |
| BlackRock | 1,864,732 | 0 | 0 | 0 | For |
| Fidelity | 1,073,532 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| Invesco | 681,557 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 391,300 | 0 | 0 | 0 | For |
| MFS | 357,693 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| DWS | 279,177 | 0 | 0 | 0 | For |
| Victory Capital | 234,777 | 0 | 0 | 0 | For |
| State Street | 209,269 | 0 | 0 | 0 | For |
| Loomis Sayles | 192,458 | 0 | 0 | 0 | For |
| Charles Schwab | 162,350 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 152,444 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 137,169 | 0 | 0 | 0 | For |
| Dimensional | 98,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 76,226 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,995 | 0 | 0 | 0 | For |
| First Trust | 68,524 | 0 | 0 | 0 | For |
| Lincoln Financial | 64,457 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 62,425 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 60,342 | 0 | 0 | 0 | For |
| AMG FUNDS | 58,521 | 0 | 0 | 0 | For |
| Jackson National | 54,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 110 asset managers. All 110 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Prior year: 94.9% for (June 6, 2025 meeting) ▲ 0.4 pts
Description as filed by funds: Election of Directors: John L. LaMattina, Ph.D.
Ligand Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: John L. LaMattina, Ph.D.”): 16,714,494 for, 819,265 withheld, per its Form 8-K filed June 9, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “In accordance with the results below, each nominee was elected to serve as a director of the Company.”
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 110 asset managers below reported 11,197,964 for, 2,021 withheld, 5 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,278,820 | 0 | 5 | 0 | For |
| BlackRock | 1,864,732 | 0 | 0 | 0 | For |
| Fidelity | 1,073,532 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| Invesco | 681,557 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 391,300 | 0 | 0 | 0 | For |
| MFS | 357,693 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| DWS | 279,177 | 0 | 0 | 0 | For |
| Victory Capital | 234,777 | 0 | 0 | 0 | For |
| State Street | 209,254 | 0 | 0 | 15 | For |
| Loomis Sayles | 192,458 | 0 | 0 | 0 | For |
| Charles Schwab | 162,350 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 152,444 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 137,169 | 0 | 0 | 0 | For |
| Dimensional | 98,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 76,226 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,995 | 0 | 0 | 0 | For |
| First Trust | 68,524 | 0 | 0 | 0 | For |
| Lincoln Financial | 64,457 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 62,425 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 60,342 | 0 | 0 | 0 | For |
| AMG FUNDS | 58,521 | 0 | 0 | 0 | For |
| Jackson National | 54,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 110 asset managers. All 110 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Prior year: 93.2% for (June 6, 2025 meeting) ▼ 0.5 pts
Description as filed by funds: Election of Directors: John W. Kozarich, Ph.D.
Ligand Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: John W. Kozarich, Ph.D.”): 16,260,105 for, 1,273,654 withheld, per its Form 8-K filed June 9, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “In accordance with the results below, each nominee was elected to serve as a director of the Company.”
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 110 asset managers below reported 10,863,413 for, 144,111 withheld, 192,466 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,278,817 | 0 | 8 | 0 | For |
| BlackRock | 1,864,732 | 0 | 0 | 0 | For |
| Fidelity | 1,073,532 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| Invesco | 681,557 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 391,300 | 0 | 0 | 0 | For |
| MFS | 357,693 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| DWS | 279,177 | 0 | 0 | 0 | For |
| Victory Capital | 234,777 | 0 | 0 | 0 | For |
| State Street | 209,254 | 0 | 0 | 15 | For |
| Loomis Sayles | 0 | 0 | 192,458 | 0 | Abstain |
| Charles Schwab | 162,350 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 152,444 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 137,169 | 0 | 0 | 0 | For |
| Dimensional | 98,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 76,226 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 0 | 68,995 | Withhold |
| First Trust | 68,524 | 0 | 0 | 0 | For |
| Lincoln Financial | 64,457 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 62,425 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 60,342 | 0 | 0 | 0 | For |
| AMG FUNDS | 58,521 | 0 | 0 | 0 | For |
| Jackson National | 54,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 110 asset managers. All 110 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Prior year: 97.9% for (June 6, 2025 meeting) ▼ 1.5 pts
Description as filed by funds: Election of Directors: Nancy R. Gray, Ph.D.
Ligand Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Nancy R. Gray, Ph.D.”): 16,915,084 for, 618,675 withheld, per its Form 8-K filed June 9, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “In accordance with the results below, each nominee was elected to serve as a director of the Company.”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 110 asset managers below reported 10,963,752 for, 43,776 withheld, 192,462 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,278,821 | 0 | 4 | 0 | For |
| BlackRock | 1,864,732 | 0 | 0 | 0 | For |
| Fidelity | 1,073,532 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| Invesco | 681,557 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 391,300 | 0 | 0 | 0 | For |
| MFS | 357,693 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| DWS | 279,177 | 0 | 0 | 0 | For |
| Victory Capital | 234,777 | 0 | 0 | 0 | For |
| State Street | 209,269 | 0 | 0 | 0 | For |
| Loomis Sayles | 0 | 0 | 192,458 | 0 | Abstain |
| Charles Schwab | 162,350 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 152,444 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 137,169 | 0 | 0 | 0 | For |
| Dimensional | 98,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 76,226 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,995 | 0 | 0 | 0 | For |
| First Trust | 68,524 | 0 | 0 | 0 | For |
| Lincoln Financial | 64,457 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 62,425 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 60,342 | 0 | 0 | 0 | For |
| AMG FUNDS | 58,521 | 0 | 0 | 0 | For |
| Jackson National | 54,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 110 asset managers. All 110 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Prior year: 93.9% for (June 6, 2025 meeting) ▲ 0.5 pts
Description as filed by funds: Election of Directors: Stephen L. Sabba, M.D.
Ligand Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Stephen L. Sabba, M.D.”): 16,552,676 for, 981,083 withheld, per its Form 8-K filed June 9, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “In accordance with the results below, each nominee was elected to serve as a director of the Company.”
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 110 asset managers below reported 11,097,748 for, 102,235 withheld, 7 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,278,818 | 0 | 7 | 0 | For |
| BlackRock | 1,864,732 | 0 | 0 | 0 | For |
| Fidelity | 1,073,532 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| Invesco | 681,557 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 391,300 | 0 | 0 | 0 | For |
| MFS | 357,693 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| DWS | 279,177 | 0 | 0 | 0 | For |
| Victory Capital | 234,777 | 0 | 0 | 0 | For |
| State Street | 209,254 | 0 | 0 | 15 | For |
| Loomis Sayles | 192,458 | 0 | 0 | 0 | For |
| Charles Schwab | 162,350 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 152,444 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 137,169 | 0 | 0 | 0 | For |
| Dimensional | 98,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 76,226 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 0 | 68,995 | Withhold |
| First Trust | 68,524 | 0 | 0 | 0 | For |
| Lincoln Financial | 64,457 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 62,425 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 60,342 | 0 | 0 | 0 | For |
| AMG FUNDS | 58,521 | 0 | 0 | 0 | For |
| Jackson National | 54,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 110 asset managers. All 110 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 97.5% for (June 6, 2025 meeting) ▲ 0.8 pts
Description as filed by funds: Election of Directors: Todd C. Davis
Ligand Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Todd C. Davis”): 17,224,372 for, 309,387 withheld, per its Form 8-K filed June 9, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “In accordance with the results below, each nominee was elected to serve as a director of the Company.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 110 asset managers below reported 11,191,310 for, 8,679 withheld, 1 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,275,762 | 0 | 1 | 3,062 | For |
| BlackRock | 1,864,732 | 0 | 0 | 0 | For |
| Fidelity | 1,073,532 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| Invesco | 681,557 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 391,300 | 0 | 0 | 0 | For |
| MFS | 357,693 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| DWS | 279,177 | 0 | 0 | 0 | For |
| Victory Capital | 234,777 | 0 | 0 | 0 | For |
| State Street | 209,254 | 0 | 0 | 15 | For |
| Loomis Sayles | 192,458 | 0 | 0 | 0 | For |
| Charles Schwab | 162,350 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 152,444 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 137,169 | 0 | 0 | 0 | For |
| Dimensional | 98,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 76,226 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,995 | 0 | 0 | 0 | For |
| First Trust | 68,524 | 0 | 0 | 0 | For |
| Lincoln Financial | 64,457 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 62,425 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 60,342 | 0 | 0 | 0 | For |
| AMG FUNDS | 58,521 | 0 | 0 | 0 | For |
| Jackson National | 54,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 110 asset managers. All 110 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 99.1% for (June 6, 2025 meeting) ▼ 0.3 pts
Description as filed by funds: Election of Directors: Martine Zimmermann, Pharm.D.
Ligand Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Martine Zimmermann, Pharm.D.”): 17,319,859 for, 213,900 withheld, per its Form 8-K filed June 9, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “In accordance with the results below, each nominee was elected to serve as a director of the Company.”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 83 asset managers below reported 8,367,942 for, 1,900 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,278,707 | 0 | 0 | 0 | For |
| Fidelity | 1,073,532 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| Invesco | 681,557 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 391,300 | 0 | 0 | 0 | For |
| MFS | 357,693 | 0 | 0 | 0 | For |
| DWS | 279,177 | 0 | 0 | 0 | For |
| Victory Capital | 234,777 | 0 | 0 | 0 | For |
| State Street | 209,269 | 0 | 0 | 0 | For |
| Charles Schwab | 162,350 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 152,444 | 0 | 0 | 0 | For |
| Dimensional | 98,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 76,226 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,995 | 0 | 0 | 0 | For |
| First Trust | 68,524 | 0 | 0 | 0 | For |
| Lincoln Financial | 63,152 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 62,425 | 0 | 0 | 0 | For |
| Russell Investments | 49,605 | 0 | 0 | 0 | For |
| Allspring | 48,079 | 0 | 0 | 0 | For |
| Brighthouse | 45,372 | 0 | 0 | 0 | For |
| Equitable | 42,681 | 0 | 0 | 0 | For |
| American Century | 40,485 | 0 | 0 | 0 | For |
| TIAA | 40,094 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 37,983 | 0 | 0 | 0 | For |
Showing the 25 largest of 83 asset managers. All 83 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
100% of fund votes cast · no official result
The 31 asset managers below reported 2,830,147 for, 1 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,864,732 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| Loomis Sayles | 192,458 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 137,169 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 60,342 | 0 | 0 | 0 | For |
| AMG FUNDS | 58,521 | 0 | 0 | 0 | For |
| Jackson National | 54,037 | 0 | 0 | 0 | For |
| Calamos | 51,250 | 0 | 0 | 0 | For |
| JPMorgan | 50,145 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 31,409 | 0 | 0 | 0 | For |
| John Hancock | 10,470 | 0 | 0 | 0 | For |
| RBB Fund Trust | 7,332 | 0 | 0 | 0 | For |
| Allianz | 6,042 | 0 | 0 | 0 | For |
| EA Series Trust | 3,649 | 0 | 0 | 0 | For |
| Brighthouse | 3,516 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,336 | 0 | 0 | 0 | For |
| Investment Managers Series Trust | 1,899 | 0 | 0 | 0 | For |
| Harbor Funds II | 1,727 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 1,317 | 0 | 0 | 0 | For |
| Lincoln Financial | 1,305 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 978 | 0 | 0 | 0 | For |
| RIVERPARK FUNDS TRUST | 881 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 554 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 280 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 252 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
95% Approved · of votes cast
Description as filed by funds: Approval of an amendment and restatement of Ligand's 2002 Stock Incentive Plan
Ligand Pharmaceuticals Incorporated’s own tally for this item (“4. The approval of an amendment and restatement of the Company's 2002 Stock Incentive Plan”): 16,643,281 for, 870,556 against — passed, per its Form 8-K filed June 9, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “In accordance with the results below, the proposal was approved.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,273,208 | 5,617 | 0 | 0 | For |
| BlackRock | 1,864,732 | 0 | 0 | 0 | For |
| Fidelity | 1,073,532 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| Invesco | 681,557 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 391,300 | 0 | 0 | 0 | For |
| MFS | 357,693 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| DWS | 279,177 | 0 | 0 | 0 | For |
| Victory Capital | 234,777 | 0 | 0 | 0 | For |
| State Street | 208,976 | 293 | 0 | 0 | For |
| Loomis Sayles | 192,458 | 0 | 0 | 0 | For |
| Charles Schwab | 162,350 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 152,444 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 137,169 | 0 | 0 | 0 | For |
| Dimensional | 98,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 76,226 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,995 | 0 | 0 | 0 | For |
| First Trust | 68,524 | 0 | 0 | 0 | For |
| Lincoln Financial | 64,457 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 62,425 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 60,342 | 0 | 0 | 0 | For |
| AMG FUNDS | 58,521 | 0 | 0 | 0 | For |
| Jackson National | 54,037 | 0 | 0 | 0 | For |
Fund voting reports, all 109 managers: 11,143,913 for, 54,921 against, 1,900 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Private Capital Management, LLC | 143,791 | 0 | 0 | 0 | For |
| Crewe Advisors LLC | 133 | 0 | 0 | 0 | For |
| Argyle Capital Management, LLC | 65 | 0 | 0 | 0 | For |
| Jackson Creek Investment Advisors LLC | 44 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 38 | 0 | 0 | 0 | For |
| Keel Point, LLC | 2 | 0 | 0 | 0 | For |
Institutional-manager reports, all 6 managers: 144,073 for.
Combines 5 wordings of this item as funds reported it.
94% Approved · of votes cast
Prior year: 92.9% for (June 6, 2025 meeting) ▲ 1.2 pts
Description as filed by funds: Approval, on an advisory basis, of the compensation of the named executive officers
Ligand Pharmaceuticals Incorporated’s own tally for this item (“3. The approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers”): 16,497,712 for, 1,021,948 against — passed, per its Form 8-K filed June 9, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “In accordance with the results below, the proposal was approved.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Ligand Pharmaceuticals Incorporated’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Say on Pay” (2 managers, 730 for); “To approve, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement” (2 managers, 71,298 for, 326 not voted).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,278,822 | 2 | 0 | 0 | For |
| BlackRock | 1,864,732 | 0 | 0 | 0 | For |
| Fidelity | 1,073,532 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| Invesco | 211,857 | 469,700 | 0 | 0 | Mixed |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 391,300 | 0 | 0 | 0 | For |
| MFS | 357,693 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| DWS | 279,177 | 0 | 0 | 0 | For |
| Victory Capital | 234,777 | 0 | 0 | 0 | For |
| State Street | 209,269 | 0 | 0 | 0 | For |
| Loomis Sayles | 192,458 | 0 | 0 | 0 | For |
| Charles Schwab | 162,350 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 152,444 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 137,169 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 105,074 | 0 | 0 | 0 | For |
| Dimensional | 98,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 76,226 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,995 | 0 | 0 | 0 | For |
| First Trust | 68,524 | 0 | 0 | 0 | For |
| Lincoln Financial | 64,457 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 62,425 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 60,342 | 0 | 0 | 0 | For |
| AMG FUNDS | 58,521 | 0 | 0 | 0 | For |
Fund voting reports, all 109 managers: 10,761,073 for, 532,771 against, 1,900 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Janus Henderson | 1,848,508 | 0 | 0 | 0 | For |
| Invesco | 223,105 | 530,903 | 0 | 0 | Mixed |
| State Street | 608,732 | 691 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 596,452 | 0 | 0 | 0 | For |
| Fidelity | 577,042 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 559,785 | 0 | 0 | 0 | For |
| NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST | 517,057 | 0 | 0 | 0 | For |
| CONGRESS ASSET MANAGEMENT CO | 485,424 | 0 | 0 | 0 | For |
| BlackRock | 445,770 | 276 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 409,386 | 0 | 0 | 0 | For |
| Stephens Investment Management Group LLC | 409,036 | 0 | 0 | 0 | For |
| Chicago Capital, LLC | 353,324 | 0 | 0 | 0 | For |
| Loomis Sayles | 341,229 | 0 | 0 | 0 | For |
| Victory Capital | 298,411 | 0 | 0 | 0 | For |
| RICE HALL JAMES & ASSOCIATES, LLC | 230,797 | 0 | 0 | 0 | For |
| Ranger Investment Management, L.P. | 230,027 | 0 | 0 | 0 | For |
| Northern Trust | 216,597 | 0 | 0 | 0 | For |
| Charles Schwab | 184,500 | 0 | 0 | 0 | For |
| VILLERE ST DENIS J & CO LLC | 173,089 | 0 | 0 | 0 | For |
| Vanguard | 159,709 | 0 | 0 | 0 | For |
| ASHFORD CAPITAL MANAGEMENT INC | 157,138 | 0 | 0 | 0 | For |
| IMPAX ASSET MANAGEMENT LLC | 152,444 | 0 | 0 | 0 | For |
| Private Capital Management, LLC | 143,791 | 0 | 0 | 0 | For |
| BESSEMER INVESTMENT MANAGEMENT LLC | 124,850 | 0 | 0 | 0 | For |
| GW&K Investment Management, LLC | 122,970 | 0 | 0 | 0 | For |
Institutional-manager reports, all 316 managers: 12,071,522 for, 871,361 against, 283 abstained, 276 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99% Approved · of votes cast
Prior year: 95.0% for (June 6, 2025 meeting) ▲ 3.6 pts
Description as filed by funds: Ratification of Ernst & Young LLP as Ligand's independent registered accounting firm
Ligand Pharmaceuticals Incorporated’s own tally for this item (“2. The ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 18,526,515 for, 257,924 against — passed, per its Form 8-K filed June 9, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “In accordance with the results below, the selection of Ernst & Young LLP was ratified.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 112 asset managers below reported 11,190,581 for, 8,432 against, 1,900 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,278,824 | 1 | 0 | 0 | For |
| BlackRock | 1,864,732 | 0 | 0 | 0 | For |
| Fidelity | 1,073,532 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| Invesco | 681,557 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 391,300 | 0 | 0 | 0 | For |
| MFS | 357,693 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| DWS | 279,177 | 0 | 0 | 0 | For |
| Victory Capital | 234,777 | 0 | 0 | 0 | For |
| State Street | 209,254 | 15 | 0 | 0 | For |
| Loomis Sayles | 192,458 | 0 | 0 | 0 | For |
| Charles Schwab | 162,350 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 152,444 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 137,169 | 0 | 0 | 0 | For |
| Dimensional | 98,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 76,226 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,995 | 0 | 0 | 0 | For |
| First Trust | 68,524 | 0 | 0 | 0 | For |
| Lincoln Financial | 64,457 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 62,425 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 60,342 | 0 | 0 | 0 | For |
| AMG FUNDS | 58,521 | 0 | 0 | 0 | For |
| Jackson National | 54,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 112 asset managers. All 112 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 20,041,061 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 11.37% |
| 2 | BlackRock | 9.30% |
| 3 | Fidelity | 5.36% |
| 4 | JANUS INVESTMENT FUND | 3.86% |
| 5 | Invesco | 3.40% |
| 6 | Franklin Custodian Funds | 2.74% |
| 7 | Delaware/Macquarie | 1.95% |
| 8 | MFS | 1.78% |
| 9 | PROFESSIONALLY MANAGED PORTFOLIOS | 1.43% |
| 10 | DWS | 1.39% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Janus Henderson | 9.22% |
| 2 | Invesco | 3.76% |
| 3 | State Street | 3.04% |
| 4 | FRANKLIN ADVISERS INC | 2.98% |
| 5 | Fidelity | 2.88% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.79% |
| 7 | NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST | 2.58% |
| 8 | CONGRESS ASSET MANAGEMENT CO | 2.42% |
| 9 | BlackRock | 2.23% |
| 10 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2.04% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Ligand Pharmaceuticals Incorporated | 8,062,678 | 40.23% | Schedule 13D, filed May 1, 2026 |
| BlackRock | 2,961,923 | 14.78% | Form 13F, quarter ended March 31, 2026 |
| Vanguard Group | 2,073,892 | 10.35% | Form 13F, quarter ended March 31, 2026 |
| Vanguard Portfolio Management | 1,109,154 | 5.53% | Schedule 13G, filed May 1, 2026 |
| Janus Henderson Group plc | 1,042,378 | 5.20% | Proxy statement (DEF 14A), proxy filed April 21, 2026 |
| Invesco | 823,604 | 4.11% | Form 13F, quarter ended March 31, 2026 |
| State Street | 778,856 | 3.89% | Form 13F, quarter ended March 31, 2026 |
| FMR (Fidelity) | 596,127 | 2.97% | Form 13F, quarter ended March 31, 2026 |
| Franklin Templeton | 573,177 | 2.86% | Form 13F, quarter ended March 31, 2026 |
| Dimensional Fund Advisors | 425,230 | 2.12% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 20,041,061 shares outstanding, as reported by Ligand Pharmaceuticals Incorporated on its Form 10-Q dated May 5, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Ligand Pharmaceuticals Incorporated's shareholder meeting held June 5, 2026, in the 2025-2026 proxy season, 398 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 4,772 separate fund positions. Their filings are grouped here into 12 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on an advisory basis, of the compensation of the named executive officers — Ligand Pharmaceuticals Incorporated's filing reports the proposal as approved, with 94% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Ligand Pharmaceuticals Incorporated's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 9, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Ligand Pharmaceuticals Incorporated’s 10-Q dated May 5, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Ligand Pharmaceuticals Incorporated proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Ligand Pharmaceuticals (LGND) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/ligand-pharmaceuticals-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.